Descriptive Study of Brain Velocity in Transcranial Doppler in Newborns Over 35 Weeks of Gestational Age in the Maternity Ward (VELOCITE)

September 3, 2019 updated by: Centre Hospitalier Universitaire Dijon

There are significant variations in blood circulation at birth with the transition from fetal to permanent circulation. These variations are particularly impacted by the closure of the arterial canal within the first 48 hours of life.

Blood circulation velocity values within the cerebral arteries have been well documented in newborns and infants a few days old. However, the initial values of these velocities and their variations during the first hours of life are not well known.

The objective of this study is to describe the evolution of brain circulation at birth in newborns over 35 weeks of gestational age and to investigate the effect of arterial canal closure on brain circulation.

Study Overview

Study Type

Observational

Enrollment (Actual)

41

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dijon, France, 21000
        • Chu Dijon Bourogne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 6 hours (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Newborns over 35 weeks of amenorrhoea

Description

Inclusion Criteria:

  • Written consent of parent
  • Newborns over 35 weeks of amenorrhoea hospitalized in the maternity ward

Exclusion Criteria:

  • person not affiliated to a health insurance scheme
  • Sepsis
  • Ductal dependent heart disease
  • Neurological impairment (anoxoischemic encephalopathy Sarnat>1, pH<7 and/or lactates>11, meningitis)
  • Obstetrical trauma (instrumental delivery by forceps, vacuum cup or spatulas)
  • Potentially lethal malformation
  • Anemia (hemoglobin<14g/dl)
  • Polyglobulia (hemoglobin>22g/dl)
  • Small for gestational age (weight<10th percentile)
  • Large for gestational age (weight>97th percentile)
  • Proven gestational diabetes (non-insulin-dependent and insulin-dependent)
  • Maternal medical treatment (cardiac or anti-epileptic)
  • Inadequate parent understanding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Right and left average velocity of the cerebral artery
Time Frame: Change from birth to 48 hours of life
Change from birth to 48 hours of life

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 19, 2018

Primary Completion (ACTUAL)

October 25, 2018

Study Completion (ACTUAL)

October 25, 2018

Study Registration Dates

First Submitted

May 29, 2018

First Submitted That Met QC Criteria

June 11, 2018

First Posted (ACTUAL)

June 12, 2018

Study Record Updates

Last Update Posted (ACTUAL)

September 4, 2019

Last Update Submitted That Met QC Criteria

September 3, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • LITZLER-RENAULT 2018 VELOCITE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe